Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
02 August 2022 - 10:00PM
Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative
pharmaceutical company focused on developing and commercializing
treatments for rare diseases, today announced that it will report
second quarter 2022 financial results on Thursday, August 11, 2022.
Management will host a conference call and live audio webcast to
discuss these results at 4:30 p.m. ET (3:30 p.m. CT).
In addition to taking live questions from participants on the
conference call, management will be answering emailed questions
from investors. Investors can email questions to:
investorrelations@etonpharma.com.The live webcast can be accessed
on the investors section of Eton’s website at
https://ir.etonpharma.com/. The conference call can be accessed by
dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international)
and refer to conference ID 9229889. An archived webcast will be
available on Eton’s website approximately two hours after the
completion of the event and for 30 days thereafter.
About Eton PharmaceuticalsEton Pharmaceuticals,
Inc. is an innovative pharmaceutical company focused on developing
and commercializing treatments for rare diseases. The company
currently commercializes ALKINDI SPRINKLE® and Carglumic Acid
tablets and has two additional rare disease products under
development, dehydrated alcohol injection and the ZENEO®
hydrocortisone autoinjector. In addition, the company’s royalty
segment is entitled to receive milestone payments or royalties on
seven different products.
Investor Contact:David
Krempadkrempa@etonpharma.com612-387-3740
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eton Pharmaceuticals (NASDAQ:ETON)
Historical Stock Chart
From Apr 2023 to Apr 2024